Mild Cognitive Impairment As Predictor for Alzheimer's Disease in Clinical Practice: Effect of Age and Diagnostic Criteria
Overview
Authors
Affiliations
Background: We investigated whether the predictive accuracy of mild cognitive impairment (MCI) for Alzheimer-type dementia (AD) in a clinical setting is dependent on age and the definition of MCI used.
Method: Non-demented subjects older than 40 (n=320) who attended a memory clinic of a university hospital were reassessed 5 years later for the presence of AD. MCI was diagnosed according to the criteria of amnestic MCI, mild functional impairment (MFI), ageing-associated cognitive decline (AACD), and age-associated memory impairment (AAMI). The main outcome measure was the area under the curve (AUC) of a receiver operating characteristic (ROC) curve. Analyses were conducted on the entire sample and on subgroups of subjects aged 40-54, 55-69 and 70-85 years.
Results: A diagnosis of AD at follow-up was made in 58 subjects. Four of them were in the 40-54 age group, 29 in the 55-69 age group and 25 in the 70-85 age group. The diagnostic accuracy in the entire sample was low to moderately high with AUCs ranging from 0.56 (AACD) to 0.75 (amnestic MCI). A good predictive accuracy with an AUC >0.80 was only observed in subjects aged 70-85 using the criteria of amnestic MCI (AUC=0.84).
Conclusions: The predictive accuracy of MCI for AD is dependent on age and the definition of MCI used. The predictive accuracy is good only for amnestic MCI in subjects 70-85 years. As subjects with prodromal AD are often younger than 70, the usefulness of MCI as predictor of AD in clinical practice is limited.
Pearson M, Wagstaff R, Williams R Brain Behav. 2024; 14(7):e3611.
PMID: 38956818 PMC: 11219301. DOI: 10.1002/brb3.3611.
Development and Effectiveness Verification of Metaverse Cognitive Therapy Contents for MCI Patients.
Oh G, Kim J, Jeong W, Oh S, Whangbo T Sensors (Basel). 2023; 23(13).
PMID: 37447859 PMC: 10346483. DOI: 10.3390/s23136010.
Gothlin M, Eckerstrom M, Rolstad S, Kettunen P, Wallin A Alzheimers Dement (Amst). 2018; 10:402-412.
PMID: 30094327 PMC: 6072671. DOI: 10.1016/j.dadm.2018.05.001.
Devlin K, Giovannetti T Neuropsychol Rev. 2017; 27(2):101-123.
PMID: 28536861 DOI: 10.1007/s11065-017-9348-2.
Fujishima M, Kawaguchi A, Maikusa N, Kuwano R, Iwatsubo T, Matsuda H J Alzheimers Dis. 2016; 56(1):75-88.
PMID: 27911297 PMC: 5240548. DOI: 10.3233/JAD-160621.